Serna Bio has built an AI-native discovery engine specifically for RNA. Our proprietary datasets give the agent a foundation that general-purpose AI and conventional drug discovery platforms don't have.
Trusted by Chiesi, Bayer and leading biotech partners from target ID to chemical optimisation.
A look at how our agent works: it reasons over our datasets, finding druggable RNA pockets and proposes selective small-molecule strategies for targets others call undruggable.
A general-purpose agent knows the literature. TRIM-AI knows our experimental data. Watch what happens when you ask both about a real target.
TRIM-AI returns experimentally validated RNA motif structures with sequence and structure information for modelling, and data to help the user make a selection.
The public agents cannot surface druggable pockets and provide further mechanistic insights, nor can they design a library as they lack access to relevant datasets & computational pipelines.
Put us to the test — take our platform for a test drive with your most challenging target.